Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Other Operating Expenses: 2021-2024

Historic Other Operating Expenses for Biofrontera (BFRI) over the last 4 years, with Dec 2024 value amounting to $36.2 million.

  • Biofrontera's Other Operating Expenses fell 51.52% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.1 million, marking a year-over-year decrease of 20.49%. This contributed to the annual value of $36.2 million for FY2024, which is 5.29% down from last year.
  • Latest data reveals that Biofrontera reported Other Operating Expenses of $36.2 million as of FY2024, which was down 5.29% from $38.2 million recorded in FY2023.
  • Biofrontera's Other Operating Expenses' 5-year high stood at $38.2 million during FY2023, with a 5-year trough of $12.0 million in FY2021.
  • For the 3-year period, Biofrontera's Other Operating Expenses averaged around $28.8 million, with its median value being $36.2 million (2024).
  • Its Other Operating Expenses has fluctuated over the past 5 years, first soared by 215.08% in 2023, then decreased by 5.29% in 2024.
  • Biofrontera's Other Operating Expenses (MRY) stood at $12.0 million in 2021, then increased by 0.67% to $12.1 million in 2022, then surged by 215.08% to $38.2 million in 2023, then dropped by 5.29% to $36.2 million in 2024.
  • Its Other Operating Expenses stands at $36.2 million for FY2024, versus $38.2 million for FY2023 and $12.1 million for FY2022.